ロード中...

Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA

The FDA Amendments Act (FDAAA) required that information for certain clinical trials, such as details about study design features and endpoints, as well as results, be publicly reported in ClinicalTrials.gov. We conducted a cross-sectional analysis of phase III trials with primary results published...

詳細記述

保存先:
書誌詳細
出版年:Trials
主要な著者: Talebi, Ramtin, Redberg, Rita F., Ross, Joseph S.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376878/
https://ncbi.nlm.nih.gov/pubmed/32703252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04603-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!